Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARCT Arcturus Therapeutics Ltd.

盘前交易 05-13 07:14:51 EDT

8.25

-0.38

-4.46%

盘前8.31

+0.06+0.73%

07:08 EDT

最高8.96	最低8.18	成交量68.97万
今开8.58	昨收8.64	日振幅9.03%
总市值2.34亿	流通市值2.17亿	总股本2,841万
成交额578.54万	换手率2.62%	流通股本2,628万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARCT","market":"US","secType":"STK","nameCN":"Arcturus Therapeutics Ltd.","latestPrice":8.25,"timestamp":1778616000000,"preClose":8.635,"halted":0,"volume":689714,"hourTrading":{"tag":"盘前","latestPrice":8.31,"preClose":8.25,"latestTime":"07:08 EDT","volume":576,"amount":4786.5715199999995,"timestamp":1778670509106,"change":0.06,"changeRate":0.007273,"amplitude":0.001394},"delay":0,"changeRate":-0.04458598726114647,"floatShares":26275300,"shares":28412537,"eps":-2.83921,"marketStatus":"盘前交易","change":-0.385,"latestTime":"05-13 07:14:51 EDT","open":8.58,"high":8.96,"low":8.18,"amount":5785358.276556,"amplitude":0.09033,"askPrice":9.54,"askSize":100,"bidPrice":8.25,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-2.83921,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778679000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.25,"preHourTrading":{"tag":"盘前","latestPrice":8.31,"preClose":8.25,"latestTime":"07:08 EDT","volume":576,"amount":4786.5715199999995,"timestamp":1778670509106,"change":0.06,"changeRate":0.007273,"amplitude":0.001394},"postHourTrading":{"tag":"盘后","latestPrice":8.57,"preClose":8.25,"latestTime":"19:59 EDT","volume":3438,"amount":28776.65,"timestamp":1778630390849,"change":0.32,"changeRate":0.038788,"amplitude":0.038788},"volumeRatio":1.2388301886705497,"impliedVol":1.3725,"impliedVolPercentile":0.8},"requestUrl":"/m/hq/s/ARCT","defaultTab":"news","newsList":[{"id":"1124503332","title":"Arcturus Therapeutics任命Dennis Mulroy为新任首席财务官，自2026年5月1日起生效 - 美国证券交易委员会文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1124503332","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124503332?lang=zh_cn&edition=full","pubTime":"2026-05-08 05:03","pubTimestamp":1778187820,"startTime":"0","endTime":"0","summary":"生物技术公司Arcturus Therapeutics Holdings Inc. 近日通过提交美国证券交易委员会的文件宣布，已正式任命Dennis Mulroy先生担任公司首席财务官，该任命自2026年5月1日起生效。Dennis Mulroy将接替现任首席财务官，全面负责公司的财务规划、资金管理、投资者关系以及合规披露等核心职能。Arcturus Therapeutics作为一家专注于信使RNA疗法和疫苗开发的生物制药企业，此次引入新任CFO，旨在进一步强化其财务架构，为后续的研发推进与商业化拓展提供坚实的财务支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155802052","title":"Arcturus Therapeutics将于2026年5月7日公布第一季度财报并举行业务更新会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1155802052","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155802052?lang=zh_cn&edition=full","pubTime":"2026-04-28 04:03","pubTimestamp":1777320195,"startTime":"0","endTime":"0","summary":"生物技术公司Arcturus Therapeutics Ltd. (ARCT) 宣布，计划于2026年5月7日发布其第一季度财务业绩。\n此次发布将全面披露公司在当季的财务表现。与此同时，公司管理层将举行一场业务更新会议，详细介绍公司的最新运营进展和未来战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146287997","title":"Arcturus Therapeutics将于2026年3月3日公布2025财年第四季度及全年财务业绩并举行公司业务更新会","url":"https://stock-news.laohu8.com/highlight/detail?id=1146287997","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146287997?lang=zh_cn&edition=full","pubTime":"2026-02-18 05:03","pubTimestamp":1771362192,"startTime":"0","endTime":"0","summary":"生物技术公司Arcturus Therapeutics Ltd. (ARCT) 已正式宣布，计划于2026年3月3日发布其2025财年第四季度及全年的财务业绩报告。此次发布将详细披露公司在指定财季及整个财年的财务表现。此外，管理层将同步举行公司业务更新会议，向投资者和市场参与者介绍最新的运营进展与战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173114596","title":"英国MHRA批准Zapomeran（Kostaive）mRNA新冠疫苗用于18岁及以上人群免疫接种","url":"https://stock-news.laohu8.com/highlight/detail?id=1173114596","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173114596?lang=zh_cn&edition=full","pubTime":"2026-01-02 21:41","pubTimestamp":1767361267,"startTime":"0","endTime":"0","summary":"英国药品和保健品监管局已正式批准ZapomeranmRNA新冠疫苗的紧急使用授权，该疫苗获准用于18岁及以上成年人群的主动免疫接种。此次批准标志着基于mRNA技术的新冠疫苗阵营再添重要力量，为应对持续演变的疫情提供了新的防控工具。作为由Arcturus Therapeutics Ltd.研发的创新型疫苗，Zapomeran采用自扩增mRNA技术平台，具有单剂接种可能诱发强效免疫应答的潜力。此次获批将扩大英国疫苗接种计划的可选范围，为不同健康需求的成年人群提供更多免疫策略选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518830278","title":"Arcturus Therapeutics Holdings Inc.盘中异动 急速下跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518830278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518830278?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:10","pubTimestamp":1741615845,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时10分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价急速跳水5.39%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3224.22%、699.68%、373.76%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Pmgc Holdings Inc.，振幅分别为41.36%、40.24%、32.14%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104598a2a73c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022104598a2a73c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518028165","title":"Arcturus Therapeutics Holdings Inc.2024财年实现净利润-80.94百万美元，同比减少172.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518028165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518028165?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536075,"startTime":"0","endTime":"0","summary":"3月10日，Arcturus Therapeutics Holdings Inc.公布财报，公告显示公司2024财年净利润为-80.94百万美元，同比减少172.25%；其中营业收入为1.38亿美元，同比减少12.66%，每股基本收益为-3.00美元。机构评级：截至2025年3月10日，当前有8家机构对Arcturus Therapeutics Holdings Inc.目标价做出预测，其中目标均价为72.62美元，其中最低目标价为48.00美元，最高目标价为140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000234abf1756b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000234abf1756b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517456003","title":"HC Wainwright & Co.：维持Arcturus Therapeutics(ARCT.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至60.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517456003","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517456003?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:52","pubTimestamp":1741369931,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Arcturus Therapeutics(ARCT.US)评级，由买入调整至买入评级, 目标价由63.00美元调整至60.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08015248604974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138230349","title":"Arcturus Therapeutics 2024年第四季度GAAP每股收益$(1.11)，不及预期$(0.44)，销售额$22.800M，不及预期$44.650M","url":"https://stock-news.laohu8.com/highlight/detail?id=1138230349","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138230349?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:07","pubTimestamp":1741295246,"startTime":"0","endTime":"0","summary":"Arcturus Therapeutics报告季度亏损每股$，比分析师的共识预期$低152.27%。这一数据比去年同期的每股亏损$减少了246.88%。公司报告季度销售额为$22.800M，比分析师的共识预期$44.650M低48.94%。以上内容来自Benzinga Earnings专栏，原文如下：Arcturus $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 152.27 percent. This is a 246.88 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $22.800 million which missed the analyst consensus estimate of $44.650 million by","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARCT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516540726","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516540726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516540726?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:34","pubTimestamp":1741026893,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时34分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速跳水5.15%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.62%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4398.57%、193.95%、179.64%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023453a25d8560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023453a25d8560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516230136","title":"Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘大幅拉升5.04%报16.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516230136","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516230136?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:51","pubTimestamp":1740775870,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时51分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.04%。截至发稿，该股报16.87美元/股，成交量22.9722万股，换手率0.85%，振幅9.15%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010451119896c792&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010451119896c792&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727043","title":"Arcturus Therapeutics Holdings Inc.盘中异动 快速下挫5.35%报16.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727043?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:53","pubTimestamp":1740408797,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时53分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速下跌5.35%。截至发稿，该股报16.82美元/股，成交量3.1745万股，换手率0.12%，振幅4.67%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242253179890fb11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242253179890fb11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513212905","title":"Arcturus Therapeutics Holdings Inc.盘中异动 临近收盘大幅上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513212905","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513212905?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:33","pubTimestamp":1740169995,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时33分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.02%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Moolec Science Sa C/Wts 涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为325.39%、253.55%、138.64%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222043316abd7f908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222043316abd7f908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512354165","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512354165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512354165?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889501,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价快速上涨5.48%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Pulmatrix, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为295.96%、102.57%、80.14%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.、Pulmatrix, Inc.，振幅分别为34.04%、26.79%、23.16%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238229889fe50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182238229889fe50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511369691","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.42%报17.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511369691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511369691?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:34","pubTimestamp":1739543671,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时34分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价大幅上涨5.42%。截至发稿，该股报17.30美元/股，成交量4.4872万股，换手率0.17%，振幅2.44%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223431a24601c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223431a24601c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ARCT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509723826","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘急速上涨5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509723826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509723826?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:17","pubTimestamp":1738768643,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时17分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价快速拉升5.86%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.19%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3901.41%、1139.89%、671.38%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为86.20%、59.80%、54.05%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231723abc387cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231723abc387cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508364149","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大跌5.07%报16.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508364149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508364149?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:36","pubTimestamp":1738593403,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时36分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价大幅下挫5.07%。截至发稿，该股报16.11美元/股，成交量1.7307万股，换手率0.06%，振幅2.57%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032236439616fc7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032236439616fc7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506125825","title":"Arcturus Therapeutics Holdings Inc.盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506125825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506125825?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074709,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价急速拉升5.37%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hepion Pharmaceuticals, Inc.涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1194.94%、562.13%、213.64%，振幅较大的相关个股有Bioline Rx Ltd、Transcode Therapeutics, Inc.、Nrx Pharmaceuticals, Inc.，振幅分别为11.43%、11.42%、10.49%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223149abbb65d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223149abbb65d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505722693","title":"Arcturus Therapeutics Holdings Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505722693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505722693?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:34","pubTimestamp":1737560043,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时34分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价快速拉升5.12%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.33%。其相关个股中，Immunoprecise Antibodies Ltd.、Dermata Therapeutics Inc C/Wts 、Nutriband Inc C/Wts 涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为815.29%、165.94%、68.90%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts ，振幅分别为53.51%、47.48%、43.41%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122233403abb4b3bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122233403abb4b3bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503423647","title":"Arcturus Therapeutics Holdings Inc.盘中异动 大幅上涨5.73%报17.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503423647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503423647?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951527,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Arcturus Therapeutics Holdings Inc.股票出现异动，股价大幅上涨5.73%。截至发稿，该股报17.54美元/股，成交量5026股，换手率0.02%，振幅1.30%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232089604b3f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232089604b3f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARCT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503333683","title":"Arcturus Therapeutics Holdings Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503333683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503333683?lang=zh_cn&edition=full","pubTime":"2025-01-15 03:17","pubTimestamp":1736882273,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日03时17分，Arcturus Therapeutics Holdings Inc.股票出现波动，股价急速跳水5.03%。Arcturus Therapeutics Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Arcturus Therapeutics Holdings Inc.公司简介：Arcturus Therapeutics Holdings Inc 是一家 RNA 药物公司，专注于罕见疾病领域的研究机会，目前重点关注肝脏和呼吸系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115031753abaaea89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115031753abaaea89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ARCT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcturusrx.com","stockEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0132},{"period":"3month","weight":0.1149},{"period":"6month","weight":0.0618},{"period":"1year","weight":-0.2882},{"period":"ytd","weight":0.3458}],"compareEarnings":[{"period":"1week","weight":0.0199},{"period":"1month","weight":0.0864},{"period":"3month","weight":0.0668},{"period":"6month","weight":0.0984},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcturus Therapeutics Holdings Inc.于2008年2月7日在以色列注册成立并开始运营，并在特拉华州重新注册成立。该公司是一家信使核糖核酸药物公司，专注于开发针对肝脏和呼吸道罕见疾病的疗法。其平台技术包括专有的自复制mRNA和脂质纳米颗粒递送系统，支持着针对鸟氨酸氨甲酰基转移酶缺乏症和囊性纤维化等疾病的候选药物管线，以及一个合作开发的COVID-19疫苗。","yearOnYearQuotes":[{"month":1,"riseRate":0.538462,"avgChangeRate":0.084619},{"month":2,"riseRate":0.538462,"avgChangeRate":0.016903},{"month":3,"riseRate":0.230769,"avgChangeRate":-0.051078},{"month":4,"riseRate":0.615385,"avgChangeRate":0.111259},{"month":5,"riseRate":0.538462,"avgChangeRate":0.084371},{"month":6,"riseRate":0.615385,"avgChangeRate":0.024246},{"month":7,"riseRate":0.538462,"avgChangeRate":0.096382},{"month":8,"riseRate":0.538462,"avgChangeRate":0.072518},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.052457},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077832},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033635},{"month":12,"riseRate":0.307692,"avgChangeRate":-0.064746}],"exchange":"NASDAQ","name":"Arcturus Therapeutics Ltd.","nameEN":"Arcturus Therapeutics Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arcturus Therapeutics Ltd.,ARCT,Arcturus Therapeutics Ltd.股票,Arcturus Therapeutics Ltd.股票老虎,Arcturus Therapeutics Ltd.股票老虎国际,Arcturus Therapeutics Ltd.行情,Arcturus Therapeutics Ltd.股票行情,Arcturus Therapeutics Ltd.股价,Arcturus Therapeutics Ltd.股市,Arcturus Therapeutics Ltd.股票价格,Arcturus Therapeutics Ltd.股票交易,Arcturus Therapeutics Ltd.股票购买,Arcturus Therapeutics Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arcturus Therapeutics Ltd.(ARCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arcturus Therapeutics Ltd.(ARCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}